文献
J-GLOBAL ID:201802267041203470
整理番号:18A0814449
健康なロシア人被験者におけるダパグリフロジン/メトホルミン徐放性固定化製剤と単成分ダパグリフロジンおよびメトホルミン徐放性錠剤の生物学的同等性【JST・京大機械翻訳】
Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects
著者 (9件):
Khomitskaya Yunona
(AstraZeneca, Moscow, Russian Federation)
,
Tikhonova Nadezhda
(AstraZeneca, Moscow, Russian Federation)
,
Gudkov Konstantin
(AstraZeneca, Moscow, Russian Federation)
,
Erofeeva Svetlana
(“Bessalar” Clinic LLC, Clinical Trials Center, Moscow, Russian Federation)
,
Holmes Victoria
(AstraZeneca, Cambridge, United Kingdom)
,
Dayton Brian
(Covance Laboratories Inc, Madison, Wisconsin, United States)
,
Davies Nigel
(IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden)
,
Boulton David W.
(AstraZeneca, Gaithersburg, Maryland, United States)
,
Tang Weifeng
(AstraZeneca, Gaithersburg, Maryland, United States)
資料名:
Clinical Therapeutics
(Clinical Therapeutics)
巻:
40
号:
4
ページ:
550-561.e3
発行年:
2018年
JST資料番号:
A1157A
ISSN:
0149-2918
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)